| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |